PPG
61
-5
HP
41
-4
DGX
39
-4
MCO
80
2
KLAC
61
-2
ITW
62
-2
STZ
63
10
ADP
69
-3
EIX
69
3
BBY
56
-2
CNX
80
4
NTAP
60
2
AVGO
69
20
FOXA
48
7
GM
58
-2
MDT
53
-2
CHD
54
6
CMA
62
-2
AVB
65
-2
FAST
46
-3
PPG
61
-5
HP
41
-4
DGX
39
-4
MCO
80
2
KLAC
61
-2
ITW
62
-2
STZ
63
10
ADP
69
-3
EIX
69
3
BBY
56
-2
CNX
80
4
NTAP
60
2
AVGO
69
20
FOXA
48
7
GM
58
-2
MDT
53
-2
CHD
54
6
CMA
62
-2
AVB
65
-2
FAST
46
-3
Financhill
Back

iShares Environmentally Aware Rl Est ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
28

ERET
iShares Environmentally Aware Rl Est ETF

Last Price:
28.80
Seasonality Move:
7.74%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
28
iShares Environmentally Aware Rl Est ETF (ERET) is a Sell

Is iShares Environmentally Aware Rl Est ETF a Buy, Sell or Hold?

  • The current iShares Environmentally Aware Rl Est ETF [ERET] share price is $28.58. The Score for ERET is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • ERET is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ERET Stock Price Chart

What is iShares Environmentally Aware Rl Est ETF's stock price today?

  • The iShares Environmentally Aware Rl Est ETF share price today is $28.58
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ERET is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

ERET Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.52 Buy
Relative Strength Index (14 RSI): 65.91 Buy
Chaikin Money Flow: 162 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.33 - 28.57) Buy
Bollinger Bands (100): (24.57 - 27.29) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

ERET Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.69 Sell
20-day SMA: 28.19 Buy
50-day SMA: 27.06 Buy
200-day SMA: 25.5 Buy
8-day EMA: 28.6 Sell
20-day EMA: 28.15 Buy
50-day EMA: 27.22 Buy
200-day EMA: 25.7 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

iShares Environmentally Aware Rl Est ETF Earnings Growth & ERET Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

iShares Environmentally Aware Rl Est ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):